Recent deals have been driven more by tax strategies than therapeutic synergies.
Morningstar StockInvestor editor Matt Coffina highlights three of the highest-quality companies we cover.
The top contract research organizations have opportunities to gain share in a rapidly growing industry.
Obamacare will benefit some sectors more than others, but poor economy and pricing pressures are the biggest challenges most health-care firms must face.
With two years of stellar returns behind us, our expectations for 2013 are more muted, but some opportunities persist.
Health-care Sector Although the median health-care stock is slightly overvalued in our opinion, we're very excited by the prospects of the health-care sector. Demographics--especially older, wealthier populations--give many of the firms we cover a strong outlook in 2007 and beyond. We're excited ...